Moreover, we previously observed that serglycin was the second most highly upregulated gene in S18 cultured cells and S18 xenografts by performing gene expression profiling and high serglycin expression was significantly correlated with EMT and adverse NPC patient outcomes. The gene discussed is SRGN; the disease is nasopharyngeal carcinoma.